Reply: Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.
Reply: Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.
复制标题
答复:Nardilysin 是一种有前途的急性冠脉综合征早期诊断生物标志物。
DOI:
10.1016/j.ijcard.2018.04.056
复制
发表时间:
2018
影响因子:
3.5
通讯作者:
Nishi E.
中科院分区:
文献类型:
--
作者:
Chen PM;Ohno M;Kimura T;Nishi E.